Copyright
©The Author(s) 2022.
World J Clin Oncol. Oct 24, 2022; 13(10): 822-834
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.822
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.822
Ref. | Number of patients | Sex | Mean age (years) | NLR threshold | Follow up (mo), mean (range) | Sample acquisition |
Erstad et al[13] | 151 | 84 M, 67 F | 58 | 5 | 41.3 ± 36.7 (2-186) | Within 6 mo prior to surgery and prior to chemotherapy |
Halazun et al[14] | 440 | 289 M, 151 F | 64 (32-88) | 5 | 24 (11-97) | 1 d prior to surgery |
Kishi et al[15] | 290 | Resection group 132 M, 68 F; non resection group 61 M, 29 F | Resection, 57; non resection, 56 | 5 | 28 (2-102) | Resection group: Before chemotherapy and before resection |
Neal et al[16] | 302 | 192 M, 110 F | 64.8 (26-85) | 5 | 29.5 (4-96) | Prior to surgery |
Hand et al[17] | 322 | 205 M, 117 F | 252 p < 70 yr; 70 p > 70 yr | 5 | 41 | On admission; the night prior to or on the morning of surgery |
Peng et al[18] | 150 | 97 M, 53 F | 58 (20-82) | 4.63 | 36 (2-126) | Within 7 d prior to surgery |
Kim et al[19] | 83 | 62 M, 21 F | 59.5 | 1.94 | NS | Within 1 wk prior to surgery |
Mao et al[20] | 183 | 123 M, 60 F | 67 p > 60 yr | 2.3 | 36.3 | Within 10 d before chemotherapy and surgery |
Neofytou et al[21] | 140 | 88 M, 52 F | 78% < 70 yr | 2.4 | 33 (1-103) | Within 10 d prior to surgery |
Giakoustidis et al[22] | 169 | 104 Μ, 65 F | 135 p < 70 yr, 34 p > 40 yr | 2.5 | 34.6 | 10 d prior to surgery - after preoperative chemotherapy |
Dupré et al[23] | 343 | 236 M, 107 F | 65.8 ± 10.9 | 2.5, 2.6 and 7.261 | 49 | Within 1 wk prior to surgery |
Hamada et al[24] | 29 | 20 M, 9 F | 63 ± 11.6 (41-83) | 4.1 | 51 (2-97) | NS |
Zeman et al[25] | 130 | 70 M, 60 F | 60 (33-82) | 5 | 39.3 | NS |
- Citation: Papakonstantinou M, Fiflis S, Christodoulidis G, Giglio MC, Louri E, Mavromatidis S, Giakoustidis D, Papadopoulos VN, Giakoustidis A. Neutrophil-to-lymphocyte ratio as a prognostic factor for survival in patients with colorectal liver metastases: A systematic review. World J Clin Oncol 2022; 13(10): 822-834
- URL: https://www.wjgnet.com/2218-4333/full/v13/i10/822.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i10.822